XKRX285130
Market cap552mUSD
Dec 24, Last price
45,550.00KRW
1D
-0.96%
1Q
-7.27%
IPO
-53.91%
Name
SK Chemicals Co Ltd
Chart & Performance
P/E
44.91
P/S
1.02
EPS
1,014.34
Div Yield, %
1.67%
Shrs. gr., 5y
-0.61%
Rev. gr., 5y
5.04%
Revenues
1.75t
-4.40%
Net income
39.86b
-79.16%
CFO
141.51b
P
Dividend
Aug 08, 2024400 KRW/sh
Earnings
Feb 11, 2025
Profile
SK Chemicals Co., Ltd. provides chemicals and life sciences products and solutions in South Korea and internationally. The company develops copolysters, coating and adhesive materials, engineering plastics, prepergs, bio materials, and 3D printing materials, as well as specialty chemicals, pharmaceutical products, and vaccines. It has a collaborate agreement with Standigm, Inc. to develop an AI-driven drug candidate for non-alcoholic steatohepatitis. The company was founded in 1969 and is headquartered in Seongnam, South Korea.
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | |
| Income | |||||||
Revenues | 1,748,777,740 -4.40% | 1,829,191,323 -12.46% | 2,089,631,876 72.03% | ||||
Cost of revenue | 1,526,406,804 | 1,463,920,189 | 1,406,549,314 | ||||
Unusual Expense (Income) | |||||||
NOPBT | 222,370,937 | 365,271,134 | 683,082,562 | ||||
NOPBT Margin | 12.72% | 19.97% | 32.69% | ||||
Operating Taxes | 4,580,808 | 5,224,848 | 168,012,086 | ||||
Tax Rate | 2.06% | 1.43% | 24.60% | ||||
NOPAT | 217,790,129 | 360,046,286 | 515,070,476 | ||||
Net income | 39,863,822 -79.16% | 191,266,055 -48.39% | 370,609,565 4,029.43% | ||||
Dividends | (29,881,812) | (67,232,073) | (26,148,258) | ||||
Dividend yield | 5.14% | 9.24% | 1.50% | ||||
Proceeds from repurchase of equity | (48,237,727) | (2,442,722) | |||||
BB yield | 6.63% | 0.14% | |||||
| Debt | |||||||
Debt current | 463,790,193 | 551,781,861 | 222,324,124 | ||||
Long-term debt | 662,798,390 | 200,015,631 | 275,539,090 | ||||
Deferred revenue | 2,110,026 | ||||||
Other long-term liabilities | 6,691,141 | 2,812,733 | 5,389,817 | ||||
Net debt | (610,198,971) | 297,329,108 | 165,679,837 | ||||
| Cash flow | |||||||
Cash from operating activities | 141,513,593 | (186,535,765) | 509,316,465 | ||||
CAPEX | (399,901,680) | (302,728,270) | (147,124,119) | ||||
Cash from investing activities | (510,390,210) | 230,967,888 | (1,566,583,813) | ||||
Cash from financing activities | 355,537,871 | 107,152,680 | 1,223,951,949 | ||||
FCF | (152,641,451) | (138,947,529) | 645,076,145 | ||||
| Balance | |||||||
Cash | 1,600,434,084 | 1,719,770,556 | 2,049,771,804 | ||||
Long term investments | 136,353,470 | (1,265,302,172) | (1,717,588,426) | ||||
Excess cash | 1,649,348,667 | 363,008,817 | 227,701,784 | ||||
Stockholders' equity | 1,522,374,076 | 1,528,214,863 | 1,386,634,091 | ||||
Invested Capital | 2,269,979,636 | 3,039,414,229 | 2,659,256,654 | ||||
ROIC | 8.20% | 12.64% | 24.47% | ||||
ROCE | 5.86% | 10.74% | 23.41% | ||||
| EV | |||||||
Common stock shares outstanding | 19,190 | 19,290 | 19,572 | ||||
Price | 30,300.00 -19.63% | 37,700.00 -57.59% | 88,900.00 -23.36% | ||||
Market cap | 581,463,727 -20.05% | 727,240,276 -58.20% | 1,739,916,129 -49.08% | ||||
EV | 578,435,610 | 1,597,353,463 | 2,429,368,707 | ||||
EBITDA | 335,256,314 | 456,736,230 | 775,957,620 | ||||
EV/EBITDA | 1.73 | 3.50 | 3.13 | ||||
Interest | 15,707,072 | 15,461,271 | 10,600,102 | ||||
Interest/NOPBT | 7.06% | 4.23% | 1.55% | ||||